MegaFill is an injectable scaffold derived from donated human tissue and used in phalloplasty to support connective tissue growth. The scaffold and the body's regenerative response combine to increase penile girth in selected patients.
This approach leverages tissue engineering: the biologic scaffold orients cellular ingrowth and collagen deposition to produce a durable augmentation. Clinicians refer to the lasting effect as the product's “final cumulative gain.”
Dr Kim explains:
“Biologic-origin scaffolds can give space and time for collagen regeneration inside the human body. The structure is already made.”
MegaFill particles are micronized (about 700–1,200 μm) so they can be injected through a needle lumen. After water is lost by the material, porosity decreases as new connective tissue forms.
MegaFill referenced here is legally available in South Korea and is KFDA approved. Different products with similar names may exist elsewhere but have different formulations and indications.
Do not assume equivalence between brands. Always verify the exact product, its regulatory status, and manufacturer instructions before clinical use.
Allograft tissue undergoes processing to remove antigenic elements. Typical processes include cryopreservation, chemical treatment, and irradiation, and two of these processes are commonly applied to MegaFill to reduce immune recognition.
Dr Kim initially avoided injectable forms due to caution, but later reviewed clinical reports and now considers MegaFill a viable option for carefully selected patients.
“E-beam sterilization kills bacteria while avoiding chemical residues and minimizing collagen damage compared to some other sterilization methods.”
Avoiding residues and preserving collagen structure support healthier tissue regrowth and lower inflammation risks.
L&C indicates higher dermis powder concentration per injected volume than some competitors.